| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |